NEW YORK (GenomeWeb News) – The University of Oxford today announced the launch of the Precision Cancer Medicine Institute, a center that will use genomics and molecular diagnostics, among other technologies, to carry out research into cancer therapies.

The institute is being funded through a £35 million grant from the Higher Education Funding Council for England through its UK Research Partnership Investment Fund. In addition, the university expects the center to receive more than £75 million from financial contributions and support in kind from partners in the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.